Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study

Go back to Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study
(NASDAQ: LEXX) Delayed: 5.79 +0.30 (5.46%)
Previous Close $5.49    52 Week High
Open $5.50    52 Week Low
Day High $5.99    P/E N/A 
Day Low $5.50    EPS
Volume 8,775       

(NASDAQ: LEXXW) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High
Open $0.00    52 Week Low
Day High $0.00    P/E N/A 
Day Low $0.00    EPS
Volume 18,997